Related Experiment Videos
The relationship between the response to growth hormone therapy and pre-treatment growth hormone secretory status
P C Hindmarsh1, P J Smith, P J Pringle
1Endocrine Unit, Middlesex Hospital, London, UK.
Insights
Growth hormone (GH) therapy response in children is linked to initial GH secretory status and dose. Pretreatment height velocity and GH levels, along with medication dosage, are crucial for assessing treatment effectiveness.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Therapy
- Biostatistics
Background:
- Growth hormone (GH) therapy is a standard treatment for children with growth deficiencies.
- Predicting individual patient response to GH therapy is essential for optimizing treatment outcomes.
- Previous studies have explored various factors influencing GH therapy efficacy.
Purpose of the Study:
- To investigate the relationship between pretreatment growth hormone (GH) secretory status and the response to Somatrem therapy in children.
- To identify key factors influencing the change in height velocity standard deviation score (SDS) during GH therapy.
- To establish a predictive model for GH therapy response.
Main Methods:
- A cohort of 35 children (aged 5.3–10.3 years) received Somatrem therapy for one year.
- A curvilinear relationship was established between pretreatment GH secretory status (x) and response (y) using the equation y = A + B (e-Cx).
- Stepwise multiple regression analysis was employed to assess the influence of GH dose and other factors on therapy response, yielding a correlation coefficient of 0.74.
Main Results:
- A significant curvilinear relationship was observed between pretreatment GH secretory status and the change in height velocity SDS.
- The dose of GH administered was identified as a critical additional factor influencing therapy response.
- The combined factors explained a substantial portion of the variance in treatment response (correlation coefficient = 0.74).
Conclusions:
- Pretreatment height velocity and GH secretory status are important predictors of response to GH therapy.
- The dose and frequency of GH administration significantly impact treatment outcomes.
- Comprehensive assessment including baseline status and dosage parameters is necessary for evaluating GH therapy effectiveness.
Abstract:
In 35 children (22 M, 13 F) aged between 5.3 years and 10.3 years who received Somatrem therapy for 1 year there was a curvi-linear relationship between pretreatment GH sensory status (x) and response (y) (change in height velocity standard deviation score (SDS)) to therapy described by the equation y = A + B (e-Cx). A, B and C are constants. Dose of GH administered was found to be an important additional factor in determining response to therapy. This was confirmed by stepwise multiple regression which resulted in a correlation coefficient of 0.74. These data suggest that in the assessment of response to GH therapy, pretreatment height velocity and/or GH secretory status as well as dose and frequency of GH administration need to be taken into account.